Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Psoriasis is a long-lasting autoimmune disease which is characterized by patches of abnormal skin.
The report details the trend, potential and market size of Psoriasis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Psoriasis Drugmarket, defines the market attractiveness level of Psoriasis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Psoriasis Drug industry, describes the types of Psoriasis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Psoriasis Drug market and the development prospects and opportunities of Psoriasis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Psoriasis Drug market in Chapter 13.
By Player:
Galderma
Johnson & Johnson
GlaxoSmithKline
Bayer
Merz Pharma
Novartis
Pfizer
Bristol-Myers Squibb
AbbVie
LEO Pharma
Valeant
By Type:
External Use
Oral
Injection
By End-User:
Hospital
Drugs Store
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Psoriasis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Psoriasis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Psoriasis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Psoriasis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Psoriasis Drug Market Analysis and Outlook to 2022
-
7.1 Global Psoriasis Drug Consumption (2017-2022)
-
7.2 United States Psoriasis Drug Consumption (2017-2022)
-
7.3 Europe Psoriasis Drug Consumption (2017-2022)
-
7.4 China Psoriasis Drug Consumption (2017-2022)
-
7.5 Japan Psoriasis Drug Consumption (2017-2022)
-
7.6 India Psoriasis Drug Consumption (2017-2022)
-
7.7 South Korea Psoriasis Drug Consumption (2017-2022)
8 Region and Country-wise Psoriasis Drug Market Analysis and Outlook to 2028
-
8.1 Global Psoriasis Drug Consumption Forecast (2022-2028)
-
8.2 United States Psoriasis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Psoriasis Drug Consumption Forecast (2022-2028)
-
8.4 China Psoriasis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Psoriasis Drug Consumption Forecast (2022-2028)
-
8.6 India Psoriasis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Psoriasis Drug Consumption Forecast (2022-2028)
9 Global Psoriasis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Psoriasis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global External Use Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Psoriasis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Store Consumption and Growth Rate (2017-2022)
10 Global Psoriasis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Psoriasis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global External Use Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Psoriasis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
11 Global Psoriasis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Psoriasis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Psoriasis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Psoriasis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Psoriasis Drug Market Competitive Analysis
-
14.1 Galderma
-
14.1.1 Galderma Company Details
-
14.1.2 Galderma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Galderma Psoriasis Drug Product and Service
-
14.2 Johnson & Johnson
-
14.2.1 Johnson & Johnson Company Details
-
14.2.2 Johnson & Johnson Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson & Johnson Psoriasis Drug Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Psoriasis Drug Product and Service
-
14.4 Bayer
-
14.4.1 Bayer Company Details
-
14.4.2 Bayer Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer Psoriasis Drug Product and Service
-
14.5 Merz Pharma
-
14.5.1 Merz Pharma Company Details
-
14.5.2 Merz Pharma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merz Pharma Psoriasis Drug Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Psoriasis Drug Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Psoriasis Drug Product and Service
-
14.8 Bristol-Myers Squibb
-
14.8.1 Bristol-Myers Squibb Company Details
-
14.8.2 Bristol-Myers Squibb Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bristol-Myers Squibb Psoriasis Drug Product and Service
-
14.9 AbbVie
-
14.9.1 AbbVie Company Details
-
14.9.2 AbbVie Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AbbVie Psoriasis Drug Product and Service
-
14.10 LEO Pharma
-
14.10.1 LEO Pharma Company Details
-
14.10.2 LEO Pharma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 LEO Pharma Psoriasis Drug Product and Service
-
14.11 Valeant
-
14.11.1 Valeant Company Details
-
14.11.2 Valeant Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Valeant Psoriasis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Psoriasis Drug
-
Figure Psoriasis Drug Picture
-
Table Global Psoriasis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriasis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriasis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Psoriasis Drug Consumption by Country (2017-2022)
-
Figure United States Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Psoriasis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Psoriasis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global External Use Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Store Consumption and Growth Rate (2017-2022)
-
Figure Global External Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Store Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Psoriasis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Psoriasis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Galderma (Foundation Year, Company Profile and etc.)
-
Table Galderma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galderma Psoriasis Drug Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Psoriasis Drug Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Psoriasis Drug Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Psoriasis Drug Product and Service
-
Table Merz Pharma (Foundation Year, Company Profile and etc.)
-
Table Merz Pharma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merz Pharma Psoriasis Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Psoriasis Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Psoriasis Drug Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Psoriasis Drug Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Psoriasis Drug Product and Service
-
Table LEO Pharma (Foundation Year, Company Profile and etc.)
-
Table LEO Pharma Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table LEO Pharma Psoriasis Drug Product and Service
-
Table Valeant (Foundation Year, Company Profile and etc.)
-
Table Valeant Psoriasis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Psoriasis Drug Product and Service
-
